About Prescribing Information
All FDA-approved drugs have what is known as prescribing information — a document that provides a comprehensive listing of information doctors need to know in order to safely and effectively prescribe the drug. This includes information on which conditions the drug has been approved to treat, its efficacy, possible side effects, drug interactions, precautions and warnings for certain patients, dosing and administration, and a detailed list of ingredients.
Although the prescribing information is intended for health care providers, there is no better source for detailed information about FDA-approved drugs. For this reason, patients who want more detailed clinical information will often consult the prescribing information.
Prescribing Information for Sandostatin LAR® Depot
The safety and efficacy of Sandostatin LAR® Depot (octreotide acetate for injectable suspension) for treating acromegaly, carcinoid syndrome, and VIPomas was established in clinical trials that included a total 194 patients. This relatively small number is explained by the rarity of these conditions. Keep in mind as well that Sandostatin LAR® Depot is a reformulation of a trusted, reliable treatment that has been used worldwide for 10 years in thousands of patients — immediate release Sandostatin® (octreotide acetate) Injection. Both share the same active ingredient, octreotide acetate.
